论文部分内容阅读
目的:探究氯吡格雷联合阿托伐他汀治疗方法对于缺血性心脑血管疾病的疗效。方法:随机选取遵义市中医院2015年6月至2016年6月收治的40例缺血性心脑血管疾病患者作为研究对象,分为对照组20例和观察组20例,在对两组患者实施治疗前,对两组患者的血常规、血脂、空腹血糖等进行检查,同时,还需要检查患者皮肤黏膜是否有出血症状。对于对照组患者,采用口服阿司匹林肠溶片的方法进行治疗,对于观察组患者,采用氯吡格雷和阿托伐他汀进行联合治疗。对于所有患者随访1年,对其短暂性脑缺血复发、非致死性脑梗死情况进行调查统计和分析。结果:对照组患者短暂性脑缺血患者再发率以及发生率均高于观察组患者。结论:对缺血性心脑血管疾病患者采用氯吡格雷联合阿托伐他汀治疗法进行治疗,能够有效预防患者疾病复发,降低脑梗死发生几率。
Objective: To investigate the therapeutic effect of clopidogrel combined with atorvastatin on ischemic cardiovascular and cerebrovascular diseases. Methods: A total of 40 patients with ischemic cardiovascular and cerebrovascular diseases admitted from Jun. 2015 to Jun. 2016 in Zunyi Hospital of Traditional Chinese Medicine were randomly divided into control group (n = 20) and observation group (n = 20) Before the implementation of treatment, two groups of patients with blood tests, blood lipids, fasting blood glucose and other tests, but also need to check the patient’s skin and mucous membranes for bleeding symptoms. Patients in the control group were treated with oral aspirin enteric-coated tablets. Patients in the observation group were treated with clopidogrel and atorvastatin. For all patients were followed up for 1 year, their transient ischemic attacks, non-fatal cerebral infarction were investigated and analyzed. Results: The incidence of recurrence and the incidence of transient ischemic attack in the control group were higher than those in the observation group. Conclusion: The treatment of patients with ischemic cardiovascular and cerebrovascular diseases with clopidogrel combined with atorvastatin treatment can effectively prevent the recurrence of patients and reduce the incidence of cerebral infarction.